Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of glibenclamide on cortical function and symptoms during hypoglycaemia in type 1 diabetes with hypoglycaemia unawareness
2007-000497-23Phase 4Completed
- Sponsor
- King's College Hospital
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of glibenclamide in diabetes mellitus type 1 (T1D) and Hypoglycaemia unawareness (HU), sponsored by King's College Hospital. Primary endpoint: Glucose threshold for increase in hypoglycaemia symptoms. Started Mar 2007; status: completed.
02
Drugs
glibenclamide
03
Conditions
diabetes mellitus type 1 (T1D)Hypoglycaemia unawareness (HU)
Beyond the preview
Go deeper on 2007-000497-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000497-23.